			Home About us Contact

AMPA Antagonist (ampa + antagonist)

Distribution by Scientific Domains

Chemistry	50%

Selected Abstracts

Selection of Antiepileptic Drug Polytherapy Based on Mechanisms of Action: The Evidence Reviewed

EPILEPSIA, Issue 11 2000
Charles L. P. Deckers
Summary: Purpose: When monotherapy with antiepileptic drugs (AEDs) fails, combination therapy is tried in an attempt to improve effectiveness by improving efficacy, tolerability, or both. We reviewed the available studies (both animal and human) on AED polytherapy to determine whether AEDs can be selected for combination therapy based on their mechanisms of action, and if so, which combinations are associated with increased effectiveness. Because various designs and methods of analysis were used in these studies, it was also necessary to evaluate the appropriateness of these approaches. Methods: Published papers reporting on AED polytherapy in animals or humans were identified by Medline search and by checking references cited in these papers. Results: Thirty-nine papers were identified reporting on two-drug AED combinations. Several combinations were reported to offer improved effectiveness, but no uniform approach was used in either animal or human studies for the evaluation of pharmacodynamic drug interactions; efficacy was often the only end point. Conclusions: There is evidence that AED polytherapy based on mechanisms of action may enhance effectiveness. In particular, combining a sodium channel blocker with a drug enhancing GABAergic inhibition appears to be advantageous. Combining two GABA mimetic drugs or combining an AMPA antagonist with an NMDA antagonist may enhance efficacy, but tolerability is sometimes reduced. Combining two sodium channel blockers seems less promising. However, given the incomplete knowledge of the pathophysiology of seizures and indeed of the exact mechanisms of action of AEDs, an empirical but rational approach for evaluating AED combinations is of fundamental importance. This would involve appropriate testing of all possible combinations in animal models and subsequent evaluation of advantageous combinations in clinical trials. Testing procedures in animals should include the isobologram method, and the concept of drug load should be the basis of studies in patients with epilepsy. [source]

Optimized Synthesis of AMPA Receptor Antagonist ZK,187638 and Neurobehavioral Activity in a Mouse Model of Neuronal Ceroid Lipofuscinosis

CHEMMEDCHEM, Issue 10 2006
Bernd Elger Dr.
Abstract Previous structure,activity relationship studies in the search for a potent, noncompetitive , -amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA) receptor antagonist led to 2,3-dimethyl-6-phenyl-12H -[1,3]dioxolo[4,5-h]imidazo[1,2-c][2,3]benzodiazepine (ZK,187638). However, the first synthesis had some drawbacks regarding reagents, processes, and overall yield, which furthermore decreased when the synthesis was scaled up. Therefore, we now report a new synthetic route for this compound which requires fewer steps and is suited for large-scale production. This compound significantly relieved the symptoms of neuromuscular deficit in mnd mice, a model of neuronal ceroid lipofuscinosis with motor neuron dysfunction. After oral administration, the concentrations of the compound in the brain and spinal cord were about threefold higher than those in the plasma. In summary, this novel AMPA antagonist is accessible through an optimized synthetic route, has good neurobehavioral activity, oral bioavailability, and favorable brain penetration. This opens new possibilities for the treatment of devastating neurological diseases that are mediated by the AMPA receptor. [source]

QSAR Study of 2,3-Benzodiazepin-4(thi)one- and 1,2-Phthalazine-Related Negative Allosteric Modulators of the AMPA Receptor: A Structural Descriptors-Based Reassessment

MOLECULAR INFORMATICS, Issue 3 2005
Peter Buchwald
Abstract In an attempt to establish statistically more rigorous and chemically more meaningful quantitative structure-activity relationship (QSAR) equations, a reassessment of a recent study of in vivo anticonvulsant activity for a set of 2,3-benzodiazepin-4(thi)one- and 1,2-phthalazine-related allosteric AMPA antagonists (n=61) is presented. Contrary to the original, relatively nonspecific descriptor set, which included, for example, a number of topological descriptors, specific structural descriptors that are much easier to interpret from a medicinal chemical point of view are used in this multiple linear regression-based approach. Only statistically significant descriptors have been retained in the final equation, and whereas they give about the same correlation as those of the original paper on the training set (r2 of 0.79 vs. 0.76, n=49), they perform much better on the test set (predictive r of 0.73 vs. 0.05; r2 of 0.78 vs. 0.08, n=12). Descriptors found to be relevant are clearly related to substitutions at known pharmacophore positions, such as those corresponding to the 2,3-, 7,8- and 4,-positions of the benzodiazepine skeleton. Therefore, by a more careful selection of the descriptor set, both an improved prediction and a more intuitive quantitative interpretation could be achieved for this set of allosteric AMPA antagonists. [source]

Complex interplay between glutamate receptors and intracellular Ca2+ stores during ischaemia in rat spinal cord white matter

THE JOURNAL OF PHYSIOLOGY, Issue 1 2006
Mohamed Ouardouz
Electrophysiological recordings of propagated compound action potentials (CAPs) and axonal Ca2+ measurements using confocal microscopy were used to study the interplay between AMPA receptors and intracellullar Ca2+ stores in rat spinal dorsal columns subjected to in vitro combined oxygen and glucose deprivation (OGD). Removal of Ca2+ or Na+ from the perfusate was protective after 30 but not 60 min of OGD. TTX was ineffective with either exposure, consistent with its modest effect on ischaemic depolarization. In contrast, AMPA antagonists were very protective, even after 60 min of OGD where 0Ca2++ EGTA perfusate was ineffective. Similarly, blocking ryanodine receptor-mediated Ca2+ mobilization from internal stores (0Ca2++ nimodipine or 0Ca2++ ryanodine), or inositol 1,4,5-trisphosphate (IP3)-dependent Ca2+ release (block of group 1 metabotropic glutamate receptors with 1-aminoindan-1,5-dicarboxylic acid, inhibition of phospholipase C with U73122 or IP3 receptor block with 2APB; each in 0Ca2+) were each very protective, with the combination resulting in virtually complete functional recovery after 1 h OGD (97 ± 32% CAP recovery versus 4 ± 6% in artificial cerebrospinal fluid). AMPA induced a rise in Ca2+ concentration in normoxic axons, which was greatly reduced by blocking ryanodine receptors. Our data therefore suggest a novel and surprisingly complex interplay between AMPA receptors and Ca2+ mobilization from intracellular Ca2+ stores. We propose that AMPA receptors may not only allow Ca2+ influx from the extracellular space, but may also significantly influence Ca2+ release from intra-axonal Ca2+ stores. In dorsal column axons, AMPA receptor-dependent mechanisms appear to exert a greater influence than voltage-gated Na+ channels on functional outcome following OGD. [source]